Morning Overview on MSN
Ozempic-style drugs were linked to about 30% lower breast-cancer odds in a 111,000-woman study
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
Observational studies provide crucial information early during epidemics and pandemics, but they often suffer from methodological shortcomings, which can be resolved. Scientific research is a ...
A systematic review finds no consistent clinical, laboratory, or treatment-related factors that predicted progression from ...
Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.
Morning Overview on MSN
Women on weight-loss drugs had 35% lower breast-cancer odds in the full study group
Women taking GLP-1 receptor agonists, the class of drugs behind semaglutide and liraglutide, had 35.1 percent lower odds of ...
This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.
• Accounting for bias is a major challenge confronting the use of observational data to gain important insights into real-world treatment effects. • No single study design will satisfy all information ...
Recent high-profile failures of Alzheimer disease treatments at the clinical trial stage have led to renewed efforts to identify and test novel interventions for Alzheimer disease and related ...
Malocclusions, or misaligned bites, refers to a condition in which the upper and lower teeth do not align properly when the mouth is closed. It can arise from a variety of factors, including tooth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results